- CH₣31.10bn
- CH₣34.30bn
- $11.16bn
Swiss stocks - Factors to watch on April 13
Focus: Patients scramble to find estrogen patches as shortage worsens after US FDA champions use
Top of the Street: Heineken, Leonardo, Ferrari, Sandoz, ACS
Goldman Sachs starts Sandoz with 'buy' on its patent rights position
RBC cuts Sandoz to 'sector-perform' on limited near-term upside
Europe Research Roundup: Endesa ,Cosmo Pharmaceuticals, Oxford Biomedica
Swiss stocks - Factors to watch on March 23
Brief: Sandoz Announces Partnership Agreement With Samsung Bioepis
Brief: Sandoz Extends USD 2.0 Billion Revolving Credit Facility To March 2031
Europe Research Roundup: Danone, Emeis, Sandoz Group
Europe Research Roundup: Aixtron, Scout24, Tate & Lyle
Refile: BUZZ-Sandoz rises after strong 2026 outlook
Switzerland's Sandoz posts FY 2025 sales beat driven by biosimilars
Brief: Sandoz FY Sales USD 11.1 Bln vs IBES Estimate USD 11.1 Bln
Swiss stocks - Factors to watch on February 25
Brief: Sandoz Confirms European Commission Approval For Ranluspec
Top of the Street: Sandoz Group, Recordati, Siegfried Holding, Banca Generali
Sandoz shares leap nearly 6% after Jefferies ups to 'buy'
Europe Research Roundup: Dassault Systemes, Ferrari, Yara